Association between a Suppressive Combined Antiretroviral Therapy Containing Maraviroc and the Hepatitis B Virus Vaccine Response

The response to the HBV vaccine in HIV-infected patients is deficient. Our aim was to analyze whether a suppressive combined antiretroviral treatment (cART) containing maraviroc (MVC-cART) was associated with a better response to HBV vaccine. Fifty-seven patients on suppressor cART were administered...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Antimicrob Agents Chemother
Autores principales: Herrero-Fernández, Inés, Pacheco, Yolanda M., Genebat, Miguel, Rodriguez-Méndez, María del Mar, Lozano, María del Carmen, Polaino, María José, Rosado-Sánchez, Isaac, Tarancón-Diez, Laura, Muñoz-Fernández, María Ángeles, Ruiz-Mateos, Ezequiel, Leal, Manuel
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2017
Materias:
Antiviral Agents
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5740301/
https://ncbi.nlm.nih.gov/pubmed/29084751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02050-17
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares